ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
17
views
0
references
Top references
cited by
49
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,533
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Candidal vulvovaginitis.
Author(s):
Robert J Sobel
Publication date:
1993-02-28
Journal:
Clinical obstetrics and gynecology
Keywords:
Administration, Intravaginal
,
Administration, Oral
,
Antifungal Agents
,
administration & dosage
,
therapeutic use
,
Candidiasis, Vulvovaginal
,
diagnosis
,
drug therapy
,
epidemiology
,
Chronic Disease
,
Decision Trees
,
Diagnosis, Differential
,
Female
,
Gynecology
,
methods
,
Humans
,
Prevalence
,
Recurrence
,
Risk Factors
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Methods by AKJournals
Author and article information
Journal
PubMed ID::
8435940
DOI::
10.1097/00003081-199303000-00021
ScienceOpen disciplines:
Chemistry
Keywords:
Administration, Intravaginal
,
Administration, Oral
,
Antifungal Agents
,
administration & dosage
,
therapeutic use
,
Candidiasis, Vulvovaginal
,
diagnosis
,
drug therapy
,
epidemiology
,
Chronic Disease
,
Decision Trees
,
Diagnosis, Differential
,
Female
,
Gynecology
,
methods
,
Humans
,
Prevalence
,
Recurrence
,
Risk Factors
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Administration, Intravaginal
,
Administration, Oral
,
Antifungal Agents
,
administration & dosage
,
therapeutic use
,
Candidiasis, Vulvovaginal
,
diagnosis
,
drug therapy
,
epidemiology
,
Chronic Disease
,
Decision Trees
,
Diagnosis, Differential
,
Female
,
Gynecology
,
methods
,
Humans
,
Prevalence
,
Recurrence
,
Risk Factors
Comments
Comment on this article
Sign in to comment
Related Documents Log
scite_
Similar content
1,533
The epidemiology of mycotic vulvovaginitis and the use of antifungal agents in suspected mycotic vulvovaginitis and its implications for clinical practice.
Authors:
L. Rainford
,
S. T. JACKSON
,
A. Miller
…
[Management of vulvovaginal atrophy: Physical therapies. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Authors:
E Maris
,
J Salerno
,
B Hédon
…
Clinical efficacy of Baofukang suppository combined with miconazole in the treatment of patients with vulvovaginal candidiasis
Authors:
R Hua
,
Y Dai
See all similar
Cited by
28
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Authors:
Adane Bitew
,
Yeshiwork Abebaw
Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis
Authors:
Diana Rosentul
,
Corine Delsing
,
Martin Jaeger
…
Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
Authors:
Atsunori Kashiwagi
,
Kenichi Kazuta
,
Satoshi Yoshida
…
See all cited by